Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetics Laboratory, |
RCV002287596 | SCV002577689 | pathogenic | Developmental and epileptic encephalopathy, 6 | 2022-10-04 | criteria provided, single submitter | clinical testing | PVS1;PM6;PM2_supporting |
Labcorp Genetics |
RCV003097722 | SCV003310284 | pathogenic | Early infantile epileptic encephalopathy with suppression bursts | 2023-03-25 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with SCN1A-related conditions. This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Tyr1279Phefs*14) in the SCN1A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SCN1A are known to be pathogenic (PMID: 17347258, 18930999). |